Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Conatus Pharmaceutic (CNAT)

Conatus Pharmaceutic (CNAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,443
  • Shares Outstanding, K 33,170
  • Annual Sales, $ 21,720 K
  • Annual Income, $ -11,390 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.84
  • Price/Sales 0.85
  • Price/Cash Flow N/A
  • Price/Book 1.05
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3300 +68.48%
on 04/28/20
0.7500 -25.87%
on 05/21/20
+0.2139 (+62.53%)
since 04/24/20
3-Month
0.2303 +141.42%
on 03/16/20
0.7500 -25.87%
on 05/21/20
+0.1465 (+35.78%)
since 02/26/20
52-Week
0.2303 +141.42%
on 03/16/20
1.0700 -48.04%
on 06/19/19
-0.2790 (-33.41%)
since 05/24/19

Business Summary

Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.6169
1st Resistance Point 0.5865
Last Price 0.5560
1st Support Level 0.5331
2nd Support Level 0.5101
3rd Support Level N/A

See More

52-Week High 1.0700
Fibonacci 61.8% 0.7492
Fibonacci 50% 0.6502
Last Price 0.5560
Fibonacci 38.2% 0.5511
52-Week Low 0.2303

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar